BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $35,920,000 | +42.9% | 237,616 | +37.7% | 2.40% | +7.5% |
| Q2 2022 | $25,139,000 | +6345.9% | 172,525 | +2775.4% | 2.24% | +2440.9% |
| Q3 2020 | $390,000 | -11.2% | 6,000 | 0.0% | 0.09% | -11.1% |
| Q2 2020 | $439,000 | +61.4% | 6,000 | -25.0% | 0.10% | +94.1% |
| Q1 2020 | $272,000 | -79.2% | 8,000 | -66.7% | 0.05% | -48.5% |
| Q4 2019 | $1,307,000 | +13.9% | 24,000 | -12.7% | 0.10% | +37.5% |
| Q3 2019 | $1,147,000 | – | 27,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |